The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Interactome INSIDER: a structural interactome browser for genomic studies
Open accessAbstract
We present Interactome INSIDER, a tool to link genomic variant information with structural protein–protein interactomes. Underlying this tool is the application of machine learning to predict protein interaction interfaces for 185,957 protein interactions with previously unresolved interfaces in human and seven model organisms, including the entire experimentally determined human binary interactome. Predicted interfaces exhibit functional properties similar to those of known interfaces, including enrichment for disease mutations and recurrent cancer mutations. Through 2,164 de novo mutagenesis experiments, we show that mutations of predicted and known interface residues disrupt interactions at a similar rate and much more frequently than mutations outside of predicted interfaces. To spur functional genomic studies, Interactome INSIDER (http://interactomeinsider.yulab.org) enables users to identify whether variants or disease mutations are enriched in known and predicted interaction interfaces at various resolutions. Users may explore known population variants, disease mutations, and somatic cancer mutations, or they may upload their own set of mutations for this purpose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationA method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · cited 1×
“We specifically focused on recurrent cancer mutations as these are known to be more likely to be functional drivers 34,35 .”
Cited by
CORUM: the comprehensive resource of mammalian protein complexes—2019
Giurgiu, M., Reinhard, J., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C., & Ruepp, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky973 · Cited by 595
Network-based prediction of protein interactions
Kovács, I. A., Luck, K., Spirohn, K., Wang, Y., Pollis, C., Schlabach, S., Bian, W., Kim, D.-K., Kishore, N., Hao, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09177-y · Cited by 471
A genome-wide positioning systems network algorithm for in silico drug repurposing
Cheng, F., Lu, W., Liu, C., Fang, J., Hou, Y., Handy, D. E., Wang, R., Zhao, Y., Yang, Y., Huang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10744-6 · Cited by 215
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107
“d by the DSD, we developed five new metrics to calculate the impact of drug targets N on the SARSCoV-2 targets +. The first (Pipeline D1) is defined as: O 343 5#2=+ ||7|| ∑ min !∈8 &∈7 B!B#TAB#(S,$), (4) where B!B(T,S) represents the diffusion state distance between nodes S and $. Since the L1-norm of two large ve…”
MethodPredictomes, a classifier-curated database of AlphaFold-modeled protein-protein interactions
Schmid, E. W., & Walter, J. C. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.01.034 · Cited by 120
“Computational strategies include homology modeling 8,9 , rigid body docking 10 , and linking genomic data with structural information 11 .”
Wang, W., Corominas, R., & Lin, G. N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00258 · Cited by 70
Paralog dependency indirectly affects the robustness of human cells
Dandage, R., & Landry, C. R. (2019) · Molecular Systems Biology · doi:10.15252/msb.20198871 · Cited by 65
PrePPI: A Structure Informed Proteome-wide Database of Protein–Protein Interactions
(2023) · doi:10.1016/j.jmb.2023.168052 · Cited by 48
Artificial intelligence approaches to human-microbiome protein–protein interactions
Lim, H., Cankara, F., Tsai, C.-J., Keskin, O., Nussinov, R., & Gursoy, A. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102328 · Cited by 39
AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
Trepte, P., Secker, C., Olivet, J., Blavier, J., Kostova, S., Maseko, S. B., Minia, I., Silva Ramos, E., Cassonnet, P., Golusik, S., et al. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00019-8 · Cited by 35
A 3D structural SARS-CoV-2–human interactome to explore genetic and drug perturbations
Wierbowski, S. D., Liang, S., Liu, Y., Chen, Y., Gupta, S., Andre, N. M., Lipkin, S. M., Whittaker, G. R., & Yu, H. (2021) · Nature Methods · doi:10.1038/s41592-021-01318-w · Cited by 32
Self-citationDeep learning methods for 3D structural proteome and interactome modeling
Lee, D., Xiong, D., Wierbowski, S., Li, L., Liang, S., & Yu, H. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102329 · Cited by 26
Self-citationStructural coverage of the human interactome
Kosoglu, K., Aydin, Z., Tuncbag, N., Gursoy, A., & Keskin, O. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad496 · Cited by 21
Duan, D., Hanson, M., Holland, D. O., & Johnson, M. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-09259-w · Cited by 15
The fitness cost of spurious phosphorylation
Bradley, D., Hogrebe, A., Dandage, R., Dubé, A. K., Leutert, M., Dionne, U., Chang, A., Villén, J., & Landry, C. R. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00200-7 · Cited by 10
(2025) · doi:10.1038/s41467-024-54176-3 · Cited by 4
An interpretable molecular framework for predicting cancer driver missense mutations
Yang, Y., Sun, W., Liu, Y., Zhang, J., & Li, M. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524289123 · Cited by 3
Cankara, F., & Doğan, T. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.09.017 · Cited by 1
Zhang, Y., Leung, A. K., Kang, J. J., Sun, Y., Wu, G., Li, L., Sun, J., Cheng, L., Qiu, T., Zhang, J., et al. (2023) · doi:10.1101/2023.03.06.531441
Self-citation
Metadata
- Authors
- Meyer, M. J., Beltrán, J. F., Liang, S., Fragoza, R., Rumack, A., Liang, J., Wei, X., & Yu, H.
- Venue
- Nature Methods
- Published
- 2018-01-01
- Volume
- 15
- Issue
- 2
- Pages
- 107-114
- ISSN
- 1548-7091 (ISSN-L)
- 1548-7105
- OpenAlex
- W2782153240
- Cited by
- 159
- References
- 22
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.